Cargando…

A novel transcription factor SIPA1: identification and verification in triple-negative breast cancer

Transcription factors (TFs) regulate the expression of genes responsible for cell growth, differentiation, and responses to environmental factors. In this study, we demonstrated that signal-induced proliferation-associated 1 (SIPA1), known as a Rap-GTPase-activating protein, bound DNA and served as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Lijuan, Zhang, Wanjun, Zhang, Xue, Wang, Jun, Nie, Jiaqi, Jin, Xiaomeng, Ma, Ying, Wang, Shi, Zhou, Xinhong, Zhang, Yilei, Xu, Yan, Tanaka, Yoshimasa, Yuan, Jingping, Liao, Xing-Hua, Gong, Yiping, Su, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457189/ https://www.ncbi.nlm.nih.gov/pubmed/37500797 http://dx.doi.org/10.1038/s41388-023-02787-3

Ejemplares similares

SIPA1 Regulates LINC01615 to Promote Metastasis in Triple-Negative Breast Cancer
por: Xiang, Yuan, et al.
Publicado: (2022)

SIPA1 Enhances Aerobic Glycolysis Through HIF-2α Pathway to Promote Breast Cancer Metastasis
por: Yao, Chenguang, et al.
Publicado: (2022)

Extracellular Vesicles Derived from SIPA1(high) Breast Cancer Cells Enhance Macrophage Infiltration and Cancer Metastasis through Myosin-9
por: Feng, Lingyun, et al.
Publicado: (2022)

Global Thrombosis Test: Occlusion by Coagulation or SIPA?
por: Clavería, Viviana, et al.
Publicado: (2021)

5-Aza-2′-deoxycytidine advances the epithelial–mesenchymal transition of breast cancer cells by demethylating Sipa1 promoter-proximal elements
por: Lu, Ang, et al.
Publicado: (2020)

Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility
por: Hsieh, Szu-Min, et al.
Publicado: (2009)

Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification
por: Zhang, Yubao, et al.
Publicado: (2021)

Sipa1 deficiency unleashes a host-immune mechanism eradicating chronic myelogenous leukemia-initiating cells
por: Xu, Yan, et al.
Publicado: (2018)

[Corrigendum] Suppression of SIPA‑1 expression may reduce bladder cancer invasion and metastasis via the downregulation of E‑cadherin and ZO‑1
por: Zhang, Ping, et al.
Publicado: (2022)

Development of simultaneous interaction prediction approach (SiPA) for the expansion of interaction network of traditional Chinese medicine
por: Rui, Mengjie, et al.
Publicado: (2020)

Development and Verification of a Prognostic Ferroptosis-Related Gene Model in Triple-Negative Breast Cancer
por: Wu, Song, et al.
Publicado: (2022)

SIPA in 10 milliseconds: VWF tentacles agglomerate and capture platelets under high shear
por: Liu, Zixiang Leonardo, et al.
Publicado: (2022)

SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis
por: Zhang, Ruyang, et al.
Publicado: (2019)

Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer
por: Crawford, Nigel PS, et al.
Publicado: (2006)

Sipa1l1 is an early biomarker of liver fibrosis in CCl(4)-treated rats
por: Marfà, Santiago, et al.
Publicado: (2016)

SIPA1 boosts migration and proliferation, and blocks apoptosis of glioma by activating the phosphorylation of the FAK signaling pathway
por: Du, Yuan, et al.
Publicado: (2022)

Structure and Activity of Streptococcus pyogenes SipA: A Signal Peptidase-Like Protein Essential for Pilus Polymerisation
por: Young, Paul G., et al.
Publicado: (2014)

Salmonella SipA mimics a cognate SNARE for host Syntaxin8 to promote fusion with early endosomes
por: Singh, Pawan Kishor, et al.
Publicado: (2018)

SIPA1L2 controls trafficking and local signaling of TrkB-containing amphisomes at presynaptic terminals
por: Andres-Alonso, Maria, et al.
Publicado: (2019)

SIPA1 Is a Modulator of HGF/MET Induced Tumour Metastasis via the Regulation of Tight Junction-Based Cell to Cell Barrier Function
por: Liu, Chang, et al.
Publicado: (2021)

Study on Mechanism of Yiqi Yangyin Jiedu Recipe Inhibiting Triple Negative Breast Cancer Growth: A Network Pharmacology and In Vitro Verification
por: Sun, Xin, et al.
Publicado: (2022)

CircRNA circ-PDCD11 promotes triple-negative breast cancer progression via enhancing aerobic glycolysis
por: Xing, Zeyu, et al.
Publicado: (2021)

Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
por: Zheng, Hongmei, et al.
Publicado: (2021)

Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer
por: Wang, Jianguo, et al.
Publicado: (2022)

Verification and Validation of a Four-Gene Panel as a Prognostic Indicator in Triple Negative Breast Cancer
por: Pariyar, Mamta, et al.
Publicado: (2022)

High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer
por: Liu, Xinkui, et al.
Publicado: (2021)

Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study
por: Li, Zhi, et al.
Publicado: (2022)

Nanomaterial Technology and Triple Negative Breast Cancer
por: Hou, Kai, et al.
Publicado: (2022)

Transcriptomic analyses identify key differentially expressed genes and clinical outcomes between triple-negative and non-triple-negative breast cancer
por: Chen, Bo, et al.
Publicado: (2018)

Current landscape of personalized clinical treatments for triple-negative breast cancer
por: Zhang, Jun, et al.
Publicado: (2022)

Case Report: A Novel Missense Variant in the SIPA1L3 Gene Associated With Cataracts in a Chinese Family
por: Yang, Duo, et al.
Publicado: (2021)

The critical role of Rap1-GAPs Rasa3 and Sipa1 in T cells for pulmonary transit and egress from the lymph nodes
por: Horitani, Shunsuke, et al.
Publicado: (2023)

Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy
por: Yang, Ruoning, et al.
Publicado: (2022)

Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer
por: Qi, Yihang, et al.
Publicado: (2022)

BRD4 Short Isoform Interacts with RRP1B, SIPA1 and Components of the LINC Complex at the Inner Face of the Nuclear Membrane
por: Alsarraj, Jude, et al.
Publicado: (2013)

Abstracts of presentations at the XXVI Congress of the Italian Phytopathological Society (SIPaV): September 16–17, 2021. University of Verona, Verona, Italy
Publicado: (2021)

Abstracts of presentations at the XXVII Congress of the Italian Phytopathological Society (SIPaV): September 21-23, 2022. University of Palermo, Palermo, Italy
Publicado: (2022)

Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer
por: Lyu, Lijuan, et al.
Publicado: (2021)

Tumor mutation burden and JARID2 gene alteration are associated with short disease-free survival in locally advanced triple-negative breast cancer
por: Zhang, Xiangmei, et al.
Publicado: (2020)

Establishment and verification of a nomogram for predicting survival in patients with triple-positive breast cancer
por: Wang, Xingguang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bqlviv59tf6iejqcberqdeglod